Human papillomavirus vaccines

Folia Biologica

Volumn 42, Issue 3, 1996, Pages 73-78

  Vonka, V ^a  

^a INSTITUTE OF HEMATOLOGY AND BLOOD TRANSFUSION   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS VACCINE;

HUMAN; NONHUMAN; REVIEW; UTERINE CERVIX CANCER; VACCINATION; VIRUS CARCINOGENESIS; VIRUS IMMUNITY; WART VIRUS;

EID: 0029890550     PISSN: 00155500     EISSN: 25337602     Source Type: Journal    
DOI: None     Document Type: Review

References (50)

1. Adam, E., Kaufman, R. L., Adler-Storthz, K., Melnick, J. L., Dressman, G. R. (1985) A prospective study of association of herpes simplex virus and human papillomavirus infection with cervical neoplasia in women exposed to diethylstilbestrol in utero. Int. J. Cancer 35, 19-25.
2. Aiba, S., Rokugo, M., Tamani, H. (1986) Immunohistological analysis of the phenomenon of spontaneous regression of numerous flat warts. Cancer 58, 1246-1251.
3. Bender, M. E. (1986) Concepts of wart regression. Arch. Dermatol. 122, 644-647.
4. Bernard, M. C. (1865) Introduction à l'étude de la médecine expérimentale. In: Poupa O. (1961) Life and Work of Claude Bernard (in Czech), p. 89-262, State Health Publishing House, Prague.
5. Bosch, F. X., Muňoz, N., de Sanjose, S., Izarzugaza. L, Gilli, M., Valadiu, P., Tomo, M. J., Moreo, P., Ascunce, N., Gonzales, L. C., Tafur, L., Kaldor, J., Guerrero, E., Aristizabal, N., Santamaria, M., de Ruiz, A., Shah, K. (1992) Risk factors for cervical cancer in Colombia and Spain. Int. J. Cancer 52, 750-758.
6. Bosch, F. X., Manos, M. M., Muňoz, N., Sherman, M., Jansen, A. M., Peto, J., Schiffman, M. H., Moreno, V., Kurman, R., Shah, K. V. (1995) Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J. Natl. Cancer Inst. 87, 796-802.
7. Brandsma, J. L. (1994) Animal models for HPV vaccine development. Papillomavirus Rep. 5, 105-111.
8. Brandsma, J. L., Yang, Z., Barthold, S. W., Johnson, E. A. (1991) Use of a rapid efficient inoculation method to induce papillomas by cottontail rabbit papillomavirus variant DNA shows that the E7 gene is required. Proc. Natl. Acad. Sci USA 88, 4816-4820.
9. Campo, M. S. (1991) Vaccination against papillomavirus. Cancer 3, 421-426.
10. Castellsagué, X., Vonka, V., Bosch, F. X., Hamšíková, E., Viladiu, P., Tafur, L., Gilli, M., Izarzugaza, I., Moreo, P., Ascunce, N., Gonzales, L. C., Navarro, C., Ghaffari, A. M., Escribá, J. M., Shah, K. V., Muňoz, N. (1995) Prognostic value of HPV serological markers in cervical cancer: a follow-up study in Colombia and Spain. 14th International Papilomavirus Conference, Quebec, Canada, Abstract No. 15.
11. Chen, L., Mizuno, M. T., Singhal, M. C., Hu, S. L., Galloway, D. A., Hellstrom, I., Hellstrom, K. E. (1992) Induction of cytotoxic T lymphocytes specific for a syngeneic tumor expressing the E6 oncoprotein of human papillomavirus type 16. J. Immunol. 148, 2617-2621.
12. Christensen, N. D., Kreider, J. W. (1990) Antibody-mediated neutralization in vivo of infectious papillomaviruses. J. Virol. 64, 3151-3156
13. Christensen, N. D., Kreider, J. W., Kan, N. C., Di Angelo, S. L. (1991) The open reading frame L2 of cottontail rabbit papillomavirus contains antibody inducing neutralizing epitopes. Virology 181, 572-579.
14. Connor, M. E., Stem, P. L. (1990) Loss of MHC class I expression in cervical carcinomas. Int. J. Cancer 46, 1029-1034.
15. Crawford, L. (1993) Prospects for cervical cancer vaccines. Cancer Surv. 16, 215-229.
16. de Sanjose, S., Hamšíková, E., Muňoz, N., Bosch, F. X., Hofmannová, V., Gilli, M., Izarzugaza, I., Viladiu, P., Tormo, M. J., Vergara, A., Muňoz, M. T., del Moral, A., Tafur, L., Shah, K., Vonka, V. (1996) Serological response to HPV 16 and cervical cancer in Spain and Colombia. Int. J. Cancer, in press.
17. Dillner, J. (1994) Antibody responses to defined HPV epitopes in cervical neoplasia. Papillomavirus Rep. 5, 35-41.
18. Evans, C. A., German, L. R, Ito, Y., Weiser, R. S. (1962) Antitumor immunity in the Shope papilloma-carcinoma complex of rabbits. II. Suppression of transplanted carcinoma V×7 by homologous papilloma vaccine. J. Natl. Cancer Inst. 629, 287-292.
19. Everest, P., Griffiths, P., Douglas, G. (1995) Live Salmonella vaccines as a route towards oral immunization. Biologicals 23, 119-124.
20. Feltkamp, M. C. W., Smith, H. L., Vierboom, M. P. C., Minnaar, R. P., de Jongh, B. M., Drigfhout, J. W., ter Schegget, J., Melief, C. J. M., Kast, W. M. (1993) Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-induced cells. Eur. J. Immunol. 23, 2242-2249.
21. Frazer, I. H. (1994) Introduction. In: Vaccines Against Virally Induced Tumours, pp. 1-3, Ciba Found. Symp. No. 187.
22. Galloway, D. A. (1992) Serological assays for the detection of HPV antibodies. In: "The Epidemiology of Cervival Cancer and Human Papillomavirus", eds. Muňoz, N., Bosch, F. X., Shah, K. V., Meheus, A., pp. 147-161, W.H.O. I.A.R.C. Scientific. Publ. No. 119, Lyon.
23. Hagensee, M. E., Yaegashi, N. Galloway, D. A. (1993) Selfassembly of human papillomavirus type I capsids by expression of the L1 protein alone or by coexpression of the L1 and L2 capsid proteins. J. Virol. 67, 315-322.
24. Hamšíková, E., Novak, J., Hofmannová, V., Muňoz, N., Bosch, F. X., de Sanjose, S., Shah, K., Roth, Z., Vonka, V. (1994) Presence of antibodies to seven human papillomavirus type 16-derived peptides to cervical cancer patients and healthy controls. J. Inf. Dis. 170, 1424-1431.
25. Jarret, W. F. H, O'Neil, B. W., Gaukroger, J. M., Smith, K., Laird, H. M., Campo, M. S. (1990) Studies on vaccination against papillomaviruses: the immunity after infection and vaccination of bovine papillomaviruses of different types. Vet. Rec. 126, 473-475.
26. Jarrett, W. F., Smith, K. T., O'Neil, B. W, Grankroger, J. M., Cbandrachud, L. M., Grindley, G. J., McGarvie, G. M., Campo, M. S. (1991) Studies on vaccination against papillomaviruses: prophylactic and therapeutic vaccination with recombinant structural proteins. Virology 184, 33-42.
27. Jenkins, O., Cason, J., Burke, K. L., Lanney, D., Gillen, A., Patel, D., McCance, D. J., Almond, J. W. (1990) An antigenic chimera of poliovims induces antibodies against human papillomavirus type 16.7. Virol. 64, 1201-1206.
28. Kimbauer, R. V., Booy, F., Cheng, N., Lowy, D. R, Schiller, J. (1992) Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic. Proc. Natl. Acad. Sci. USA 89, 12180-12184.
29. Lehtinen, M., Hakama, M., Aaran, R.-K., Aromaa, A., Knekt, P., Leinikki, P., Maatela, J. P. R., Teppo, L. (1993) Herpes simplex virus type 2 infection and cervical cancer: a prospective study of 12 years of follow-up in Finland. J. Virol. 3, 333-338.
30. Lin, Y.-L., Borenstein, L. A., Seivakumar, R. A., Wettstein, F. O. (1992) Effective vaccination against papilloma development by immunization with L1 or L2 structural protein of cottontail rabbit papillomavirus. Virology 187, 612-619.
31. Lutzner, M. A. (1985) Papillomavirus lesions in immunodepression and immunosuppression. Clin. Dermatol. 3, 165-169.
32. Malejczyk, J., Malewski, S., Jablonska, S., Rogozinski, T. T., Orth, G. (1989) Abrogated NK-cell lysis of human papillomavirus (HPV)-16 bearing keratinocytes in patients with pre-cancerous HPV-induced anogenital lesions. Int. J. Cancer 43, 209-214.
33. McDougall, J. K. (1994) Immortalization and transformation of human cells by human papillomavirus. Curr. Top. Microbiol. Immunol. 186, 101-119.
34. Meneguzzi, G., Cerni, C., Kieny, M. P., Lathe, R. (1991) Immunization against human papillomavirus type 16 tumor cells with recombinant vaccinia viruses expressing E6 and E7. Virology 181, 62-69.
35. Muňoz, N., Bosch, F. X., de Sanjose, S., Tafur, L., Izarzugaza, I., Gilli, M., Viladiu, P., Navarro, C., Martos, C., Ascuence, N., Gonzales, L. C., Kaldor, J. M., Guerrero, E., Lorincz, A., Santamaria, M., de Ruiz, A., Aristizabal, N., Shah, K. (1992) The causal link between papillomavirus and invasive cervical cancer: a population-based case-control study in Colombia and Spain. Int. J. Cancer 52, 743-749.
36. Nair, S., Zhon, F., Reddy, R., Huang, L., Rouse, B. (1992) Soluble proteins delivered to dendritic celis via pH-sensitive liposomes induce primary cytotoxic T lymphocyte responses in vitro. J. Exp. Med. 175, 609-612.
37. Parkin, D. M., Pisani, P., Ferlay, J. (1993) Estimates of the worldwide incidence of eighteen major cancers in 1985. Int. J. Cancer 54, 594-601.
38. Rothman, K. J. (1976) Causes. Am. J. Epidemiol. 104, 90-95.
39. Shiel, A. G. (1992) Development of malignancy following renal transplantation in Australia and New Zealand. Transplant. Proc. 24, 1275-1278.
40. Spradbrow, P. B., Wilson, B. E., Hoffmann, D., Kelly, W. R., Francis. J. (1977) Immunotherapy of bovine ocular squamous cell carcinomas. Vet. Rec. 100, 376-378.
41. Stanley, M., Coleman, N., Chambers, M. (1994) The host response to lesions induced by human papillomavirus. In: Vaccines Against Virally Induced Tumors, pp. 21-31, Ciba Found. Symp. No. 187, London.
42. Stauss, H. J., Davies, H., Sadovnikova, E., Chain, B., Horowitz, N.,Sinclair, C. (1992) Induction of cytotoxic T lymphocytes with peptides in vitro: identification of candidate T-cell epitopes in human papillomavirus. Proc. Natl. Acad. Sci. USA 89, 7871-7875.
43. Taghian, A., Huang, P. (1995) The nude mice and SCBD mice as a tumour model in experimental cancer biology. Cancer J. 8, 52-58.
44. Tay, S. K., Jenkins, D., Maddox, P. H., Canipion, M., Singer, A. (1987) Subpopulation of Langerhans cells in cervical neoplasia. Br. J. Obstet. Gynaecol. 94, 10-15.
45. Tindle, R. W., Frazer, I. H. (1994) Immune responses to human papillomaviruses and the prospects for human papillomavirus specific immunization. Curr. Top. Microbiol. Immunol. 186, 217-253.
46. Tomassino, M., Crawford, L. (1995) Human papillomavirus E6 and proteins which deregulate the cell cycle. BioEssays 17, 509-518.
47. Vogel, F. R., Sarver, N. (1995) Nucleic acid vaccines. Clin. Microbiol. Rev. 8, 406-410.
48. Vonka, V., Kaňka, J., Hirsch, I., Závadová, M., Krčmář, M., Suchánková, A., Řezáčová, D., Brouček, J., Pres, M., Domorázková, E., Svoboda, B., Havránková, A., Jelínek, J. (1984) Prospective study on the relationship between cervical neoplasia and herpes simplex type 2 virus. II. Herpes simplex type 2 antibody presence in sera taken at enrollment. Int. J. Cancer 33, 61-66.
49. Zhou, J., Sun. X. Y., Stenzel, D. Y, Frazer, I. H. (1991) Expression of vaccinia recombinant HPV 16L1 and L2 ORF proteins in epithelial cells is sufficient for assembly of HPV virion-like particles. Virology 185, 251-257.
50. zur Hausen, H. (1991) Human papillomaviruses in the pathogenesis of anogenital cancer. Virology 184, 9-13.